$GHDX News 4 stocks with charts pointing higher 6:58

New Post Public Reply Private Reply Replies (0) Message Board

Apr 17, 2014 at 12:37 PM

$GHDX News

4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Genomic Health up 15% on business update, earnings 10:52 a.m. Aug. 9, 2012 - Val Brickates Kennedy
Stocks to watch Tuesday: Kenexa, Coinstar, ViaSat 7:51 a.m. Feb. 7, 2012 - MarketWatch
Biotech analysts lukewarm on diagnostic stocks 4:16 p.m. Sept. 29, 2011 - Val Brickates Kennedy
Updates, advisories and surprises 7:01 p.m. Nov. 9, 2010 - MarketWatch
Genomic Health soars as drug indexes ease 12:14 p.m. Nov. 9, 2010 - Val Brickates Kennedy
Genomic Health rockets as drug indexes ease 11:14 a.m. Nov. 9, 2010 - Val Brickates Kennedy
Setting up to retest the 2008 lows 9:27 a.m. Sept. 11, 2008 - Michael Ashbaugh
Genomic Health up 4.4% at $17.48 9:40 a.m. March 27, 2007 - Tomi Kilgore
Genomic Health upped to outperform at Piper Jaffray 7:36 a.m. March 27, 2007 - Tomi Kilgore
Updates, advisories and surprises 11:01 p.m. Feb. 7, 2007 - MarketWatch
Wednesday's biggest stock gainers and decliners 7:26 p.m. Feb. 7, 2007 - Michael Baron
Genomic Health shares fall as loss widens in fourth quarter 11:32 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares fall on Q4 results 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Genomic Health shares dwon 7.9% at $19.79 11:27 a.m. Feb. 7, 2007 - Gabriel Madway
Wednesday's biggest stock gainers and decliners 7:00 p.m. Jan. 17, 2007 - Michael Baron
Drug stocks rise, but Isis slides on note offering 5:35 p.m. Jan. 17, 2007 - Val Brickates Kennedy
Genomic Health down 9.9% at $21.33 10:48 a.m. Jan. 17, 2007 - Tomi Kilgore
Genomic Health cut to equal weight at Lehman Bros. 10:26 a.m. Jan. 17, 2007 - Tomi Kilgore
Wednesday's biggest stock gainers and decliners 5:56 p.m. Jan. 10, 2007 - Michael Baron

Balanced View on Genomic Health - Analyst Blog 3:20 p.m. April 8, 2014 - Zacks.com
Genomic Health, Inc. (GHDX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. April 4, 2014 - Zacks.com
Bear of the Day: Genomic Health (GHDX) - Bear of the Day 4:09 a.m. April 3, 2014 - Zacks.com
Genomic Health Unveils Oncotype DX Data - Analyst Blog 6:15 p.m. March 20, 2014 - Zacks.com
Foundation Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
Fountain Medicine Lockup Expiration Could Flood The Market, Depressing Share Price 12:57 p.m. March 13, 2014 - Seeking Alpha
10-K: GENOMIC HEALTH INC 4:44 p.m. March 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zacks Rank #5 Additions for Thursday - Tale of the Tape 10:30 a.m. Feb. 27, 2014 - Zacks.com
5 Biotechnology Stocks to Sell Now 3:15 a.m. Feb. 19, 2014 - InvestorPlace.com
What Makes Genomic Health (GHDX) a Strong Sell? - Tale of the Tape 9:45 a.m. Feb. 13, 2014 - Zacks.com
Weakness seen in Genomic Health (GHDX): Stock Tumbles 9.0% - Tale of the Tape 9:43 a.m. Feb. 6, 2014 - Zacks.com
Q4 Loss Narrower Than Expected at Genomic, Revs Up Y/Y - Analyst Blog 11:30 a.m. Feb. 5, 2014 - Zacks.com
UPDATE: Bank of America Reiterates on Genomic Health as 2014 Outlook is Below Expectations 10:15 a.m. Feb. 5, 2014 - benzinga.com
Genomic Health Management Discusses Q4 2013 Results - Earnings Call Transcript 9:10 p.m. Feb. 4, 2014 - Seeking Alpha
Q4 2013 Genomic Health Inc Earnings Conference call (Webcast) 5:25 p.m. Feb. 4, 2014 - Seeking Alpha
A New Approach to Prostate Cancer 8:12 p.m. Jan. 13, 2014 - The Wall Street Journal Interactive Edition
MannKind Corp. (MNKD) Surges: Stock Moves 18.4% Higher - Tale of the Tape 10:21 a.m. Jan. 10, 2014 - Zacks.com
InterMune (ITMN) Jumps: Stock Rises 9.5% - Tale of the Tape 9:57 a.m. Jan. 10, 2014 - Zacks.com
Agenus (AGEN) Jumps: Stock Adds 8.8% in Session - Tale of the Tape 9:51 a.m. Jan. 10, 2014 - Zacks.com
Cytori Therapeutics (CYTX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 10:21 a.m. Jan. 9, 2014 - Zacks.com

Genomic Health Announces Presentation of New Data Further Supporting Use of Oncotype DX® in Europe 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Genomic Health Announces Year-End 2013 Financial Results, Provides 2014 Financial Outlook 5:01 p.m. Feb. 4, 2014 - PR Newswire - PRF
Genomic Health Announces Results of Oncotype DX® Colon Cancer Studies Presented at 2014 American Society of Clinical Oncology Gastrointestinal Cancer (ASCO GI) Symposium 9:00 a.m. Jan. 29, 2014 - PR Newswire - PRF
Genomic Health to Announce Fourth Quarter and Year-End 2013 Financial Results and Host Conference Call on Tuesday, February 4, 2014 9:00 a.m. Jan. 28, 2014 - PR Newswire - PRF
Specialised Therapeutics Australia Partners with Genomic Health Inc. to Deliver Novel Genomic Test to Breast Cancer Patients 9:00 a.m. Jan. 7, 2014 - PR Newswire
Genomic Health Announces Presentation at J.P. Morgan Healthcare Conference 5:00 p.m. Jan. 6, 2014 - PR Newswire
Healthcare Companies Announce Study Results, Acquisitions and Company Updates - Research Report on Sirona Dental Systems, Ligand Pharmaceuticals, Genomic Health, Unilife, and Sykes 9:00 a.m. Dec. 24, 2013 - PR Newswire
Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health 9:00 a.m. Dec. 16, 2013 - PR Newswire
Genomic Health Announces Presentation of New Oncotype DX® Studies Underscoring Unique Value of the Test in Early-Stage Breast Cancer at the 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium 9:35 a.m. Dec. 14, 2013 - PR Newswire
Invitae Offers BRCA1/BRCA2 Testing, Providing Clinicians With a Reliable, Fast, Affordable Option for Patients 9:30 a.m. Dec. 11, 2013 - BusinessWire
Invitae Completes $40 Million Series E Financing 10:00 a.m. Dec. 10, 2013 - BusinessWire
Genomic Health Announces Presentation of Oncotype DX® Studies at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) 9:00 a.m. Dec. 4, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - PR Newswire
Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer 5:01 p.m. Nov. 25, 2013 - BusinessWire
Genomic Health Announces Publication of Oncotype DX® Prostate Cancer Test Analytical Validation Study 9:00 a.m. Nov. 22, 2013 - PR Newswire
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development 9:00 a.m. Nov. 19, 2013 - PR Newswire
Company Statements, Study Results, Stock Movements, Awards and Stock Splits - Research Report on WebMD, Cerner, Waters, Medidata and Genomic Health 9:00 a.m. Nov. 18, 2013 - PR Newswire
Genomic Health Announces Colon Cancer Publication in Journal of Clinical Oncology Supporting Wider Oncotype DX® Utilization 9:00 a.m. Nov. 13, 2013 - PR Newswire
Companies in the Healthcare Sector Report Financial Results, and Scheduled Conference calls - Research Report on OXiGENE, BioTelemetry, Abiomed, Emeritus, and Genomic Health 9:00 a.m. Nov. 11, 2013 - PR Newswire
Genomic Health Announces Third Quarter 2013 Financial Results and Business Progress 5:01 p.m. Nov. 5, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unpacking RAGEism: Power Dynamics in U.S. Policies

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Shareholder Rights in Focus: Examining Key Buyouts

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Red-Eye Flights Surge, Driven By Western U.S. Routes

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Veho's Role in Redefining Beauty E-Commerce Delivery

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Mobile Iron IV Expansions: Targeting Texas Health Needs

Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

RealNex Navigator Upgrades Unveil Vast CRE Capabilities

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Midlife ADHD in Women: New Challenges and Solutions

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...